Literature DB >> 12217473

Cardiac troponins.

John Sarko1, Charles V Pollack.   

Abstract

Cardiac troponins I and T are proteins integral to the function of cardiac muscle. They are very sensitive markers for the detection of myocardial damage, and the ability to assay their serum levels accurately and quickly have revolutionized the concepts of minor myocardial injury and infarction. They are also powerful prognostic indicators of future adverse cardiac events. Limitations, more of troponin T than I, include decreased specificity in renal failure and skeletal muscle disease. Rapid, whole blood assays are now available that can be done at the patient's bedside. This review discusses the cardiac troponins, their biochemistry, the assays for them currently available, and their roles in the evaluation of cardiac disease in the Emergency Department (ED).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217473     DOI: 10.1016/s0736-4679(02)00463-8

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  11 in total

1.  Lack of association between cardiac troponin T and D-dimer in the evaluation of myocardial damage.

Authors:  Rafael Noal Moresco; Luís Cláudio Rosa Vargas; Ronald Halla Júnior; Lúcia Mariano da Rocha Silla
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

2.  High cardiac troponin I plasma concentration in a calf with myocarditis.

Authors:  Tolga Karapinar; Durrin Ozlem Dabak; Tuncay Kuloglu; Hakan Bulut
Journal:  Can Vet J       Date:  2010-04       Impact factor: 1.008

3.  Release of brain natriuretic-related peptides (BNP, NT-proBNP) and cardiac troponins (cTnT, cTnI) in on-pump and off-pump coronary artery bypass surgery.

Authors:  Valérie Guerin; Said Ben Ayed; Shaida Varnous; Jean-Louis Golmard; Pascal Leprince; Jean-Louis Beaudeux; Iradj Gandjbakhch; Maguy Bernard
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Autonomic and cellular mechanisms mediating detrimental cardiac effects of status epilepticus.

Authors:  Steven L Bealer; Jason G Little; Cameron S Metcalf; Amy L Brewster; Anne E Anderson
Journal:  Epilepsy Res       Date:  2010-07-21       Impact factor: 3.045

Review 5.  Perioperative myocardial infarction in non-cardiac surgery. Pathophysiology and clinical implications.

Authors:  Pietro Amedeo Modesti; Ignazio Simonetti; Giuseppe Olivo
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

6.  Analysis of Time Series Gene Expression and DNA Methylation Reveals the Molecular Features of Myocardial Infarction Progression.

Authors:  Yuru Han; Baoyu Duan; Jing Wu; Yanjun Zheng; Yinchen Gu; Xiaomeng Cai; Changlian Lu; Xubo Wu; Yanfei Li; Xuefeng Gu
Journal:  Front Cardiovasc Med       Date:  2022-06-24

7.  Physiological Changes, Activity, and Stress During a 100-km-24-h Walking-March.

Authors:  Marc Jörres; Hanns-Christian Gunga; Mathias Steinach
Journal:  Front Physiol       Date:  2021-03-11       Impact factor: 4.566

Review 8.  Cardiac injury biomarkers in paediatric age: Are we there yet?

Authors:  Ana L Neves; Tiago Henriques-Coelho; Adelino Leite-Moreira; José C Areias
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

9.  Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats.

Authors:  Dustin L Cooper; Derek E Murrell; Christopher M Conder; Victoria E Palau; Grace E Campbell; Shaun P Lynch; James W Denham; Angela V Hanley; Kenny W Bullins; Peter C Panus; Krishna Singh; Sam Harirforoosh
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

Review 10.  Assessment of Developmental Toxicants using Human Embryonic Stem Cells.

Authors:  Eui-Ju Hong; Eui-Bae Jeung
Journal:  Toxicol Res       Date:  2013-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.